News

Search:
 Search

Latest News | 23 May 2013

Senate Advances Compounding, Track and Trace Legislation with an Eye on July Passage

0 Likes

The US Senate's Health, Education, Labor and Pensions (HELP) Committee has advanced two long-sought-after proposals that would overhaul the framework by which the US Food and Drug Administration (FDA) Read More...


Latest News | 16 April 2013

Hamburg Defends Agency's Response to Compounding Crisis, Floats User Fees as Potential Solution

0 Likes

Arguing that the issue of the safety of compounded pharmaceutical products is now at a "critical point," US Food and Drug Administration (FDA) Commissioner Margaret Hamburg plans to tell legislators Read More...


Latest News | 27 March 2013

President Signs into Law Budget Bill that Restores FDA's Authority to Spend User Fees

0 Likes

A new budget resolution passed into law by President Barack Obama on Wednesday will for the first time allow the US Food and Drug Administration (FDA) to spend tens of millions of annual user fees the Read More...


Latest News | 25 March 2013

Hamburg: User Fees Might be Solution for Funding Increasing Regulation of Compounding Industry

0 Likes

Since the 1990s, the US Food and Drug Administration (FDA) has leveraged industry-paid user fees for an increasing number of product areas, starting with prescription drugs and branching off into Read More...


Latest News | 21 March 2013

FDA Authorized to Spend New User Fees Under Just-Passed Senate Bill

0 Likes

The US Senate has approved a measure that would both continue funding government agencies at their currently-appropriated levels and grant the US Food and Drug Administration (FDA) access to user fees Read More...


Latest News | 8 March 2013

MDUFA Goals Met in 74-85% of Cases in 2012, FDA Report Says

0 Likes

The US Food and Drug Administration (FDA) has released a new congressional report it wrote regarding its performance under the final fiscal year of the Medical Device User Fee Act (MDUFA), a law Read More...


Latest News | 5 March 2013

Legislation Corrects User Fee Oversight for Medical Devices, Generic Drugs

0 Likes

Legislators have introduced a piece of legislation in the US House of Representatives that would allow the US Food and Drug Administration (FDA) to spend user fees that it had previously been able to Read More...


Latest News | 1 March 2013

Following FDASIA, Veterinary User Fee Bills Prepare for Congressional Scrutiny

0 Likes

Congress has begun the process of taking up two bills that stand to make reforms to the user fee process for innovative and generic veterinary pharmaceutical products with the stated goals of Read More...


Latest News | 15 February 2013

Sebelius Writes to Congress, Reminding Them of Sequester's Impact on User Fees

0 Likes

US Department of Health and Human Services (DHHS) Secretary Kathleen Sebelius has quietly confirmed what many in the industry have long known: User fees paid to the US Food and Drug Administration Read More...


Latest News | 16 January 2013

FDA Sets Facility Registration Fees for Manufacturers of Generic APIs, Finished Dosage Forms

0 Likes

The US Food and Drug Administration (FDA) has published the user fee rates for facilities that manufacture active pharmaceutical ingredients (APIs) and finished dosage forms (FDF) for the current Read More...


1 2 3 4 5
RF Today is Regulatory Focus' daily news brief. Each edition contains the top global regulatory news stories about pharmaceuticals, medical devices, biotechnology and more. Learn more

New Regulatory Focus Apps for iPad and iPhone